Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2014, Article ID 906759, 4 pages
http://dx.doi.org/10.1155/2014/906759
Case Report

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)

1Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Honjyo 1-1-1, Chuo-ku, Kumamoto 860-8556, Japan
2Department of Surgery, Kumamoto Shinto General Hospital, Shinyashiki 1-17-27, Chuo-ku, Kumamoto 962-8655, Japan
3Department of Multidisciplinary Treatment for Gastroenterological Cancer, Kumamoto University Hospital, Honjyo 1-1-1, Chuo-ku, Kumamoto 860-8556, Japan

Received 27 February 2014; Accepted 26 May 2014; Published 17 June 2014

Academic Editor: Ruud J. L. F. Loffeld

Copyright © 2014 Hiroyuki Komori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Beppu, Y. Miyamoto, Y. Sakamoto et al., “Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival,” Annals of Surgical Oncology, vol. 21, supplement 3, pp. 405–413, 2014. View at Google Scholar
  2. J. N. Primrose, “Surgery for colorectal liver metastases,” British Journal of Cancer, vol. 102, no. 9, pp. 1313–1318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. C. Tsim, A. E. Frampton, N. A. Habib, and L. R. Jiao, “Surgical treatment for liver cancer,” World Journal of Gastroenterology, vol. 16, no. 8, pp. 927–933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Beppu, Y. Sakamoto, K. Hasegawa et al., “A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, no. 1, pp. 72–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Kurkjian and S. Kummar, “Advances in the treatment of metastatic colorectal cancer,” American Journal of Therapeutics, vol. 16, no. 5, pp. 412–420, 2010. View at Google Scholar · View at Scopus
  6. H. M. Pinedo and G. F. J. Peters, “Flourouracil: biochemistry and pharmacology,” Journal of Clinical Oncology, vol. 6, no. 10, pp. 1653–1664, 1984. View at Google Scholar · View at Scopus
  7. V. K. Sharma and G. Sethuraman, “Adverse cutaneous reactions to drugs: an overview,” Journal of Postgraduate Medicine, vol. 42, no. 1, pp. 15–22, 1996. View at Google Scholar · View at Scopus
  8. Y. Maehara, “S-1 in gastric cancer: a comprehensive review,” Gastric Cancer, vol. 6, supplement 1, pp. 2–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. C. Quincy, A. H. Lisa, S. Garry et al., “Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies,” Clinical Cancer Research, vol. 10, no. 15, pp. 4913–4921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Beppu, M. Iwatsuki, H. Okabe et al., “A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol,” Journal of Gastroenterology, vol. 45, no. 2, pp. 211–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Q. Xiong and J. A. Ajani, “Treatment of colorectal cancer metastasis: the role of chemotherapy,” Cancer and Metastasis Reviews, vol. 23, no. 1-2, pp. 145–163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Wiboon, L. M. Howard, M. Fiona et al., “Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer,” Pharmacotherapy, vol. 17, no. 5 I, pp. 881–886, 1997. View at Google Scholar · View at Scopus
  14. T. André, C. Louvet, F. Maindrault-Goebel et al., “CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer,” European Journal of Cancer, vol. 35, no. 9, pp. 1343–1347, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Goto, Y. Yamada, H. Yasui et al., “Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer,” Annals of Oncology, vol. 17, no. 6, pp. 968–973, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tsunoda, N. Yasuda, K. Nakao et al., “Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer,” Oncology, vol. 77, no. 3-4, pp. 192–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Haller, M. L. Rothenberg, A. O. Wong et al., “Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma,” Journal of Clinical Oncology, vol. 26, no. 28, pp. 4544–4550, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yamada, M. Tahara, T. Miya et al., “Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer,” British Journal of Cancer, vol. 98, no. 6, pp. 1034–1038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Vauthey, T. M. Pawlik, D. Ribero et al., “Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2065–2072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. D. Peppercorn, R. H. Reznek, P. Wilson, M. L. Slevin, and R. K. Gupta, “Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer,” British Journal of Cancer, vol. 77, no. 11, pp. 2008–2011, 1998. View at Google Scholar · View at Scopus